Dear Colleagues, PATH is pleased to share with you key findings on the technical and commercial feasibility of stabilizing vaccines. These findings are outlined in a recent guest editorial published in the journal Human Vaccines. In the editorial, PATH's Debra Kristensen, group leader of Vaccin...

Thanks Julian. It really helped. I stress so much on anti freezing the H1N1 vaccine during my country wide lectures that I needed to be sure of my claims. Frankly it would have been better for a H1N1 vccine without VVM to be freeze resistant, as opertaionally it is much easier for vaccinators in ...

New bivalent polio vaccine simplifies logistics in hard-to-reach areasby Ian Lewis, UNICEF Supply Division Since 2005, the Global Polio Eradication Initiative (GPEI) has increasingly used monovalent oral polio vaccines (OPVs) in the fight against the two wild poliovirus strains still in circulation ...

A few more of the HCWM presentations that were made at the annual meeting of the Safe Injection Global Network (SIGN), which was held from 30 November to 2 December 2009. Thanks once again to Selma Khamassi for sharing them with the forum. Non-Incineration Medical Waste Treatment Pilot Project at Ba...

The annual meeting of the Safe Injection Global Network (SIGN) was held from 30 November to 2 December 2009. The following are some of the presentations on Healthcare Waste Management. Many thanks to Selma Khamassi for sending these to me to be shared with TechNet21 readers. HCWM--10 Years: Yves Cha...

Dear Friends, Here is more on intradermal delivery of vaccines. As many as 10 vaccines can be given intradermally to spare costs as well as doses, but unfortunately this is not promoted by vested interests. Please see the link on the WHO website: http://www.who.int/immunization_delivery/systems_poli...

Dear Friends, Here is more on intradermal Influenza vaccine: http://www.ncbi.nlm.nih.gov/pubmed/18652550                 http://content.nejm.org/cgi/content/full/351/22/2286 The government of India is importing 2.8 million ...

Dear Friends, After Virorab, Sanofi-Pasteur has come out with a low-cost Intradermal Influenza vaccine Intanza® / IDflu® vaccine*, see the link below, http://198.73.159.214/sanofi-pasteur2/ImageServlet?imageCode=24890&siteCode=SP_CORP Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology)Dir...

Dear Friends, It is a great pleasure to know that now Virorav has also come out with the intradermal option (attachment). This will be a further boost to the intradermal ARV campaign in India to controll rabies. After Rabipur, Abhyrab and Indirav, this will be the fourth drug offer...

We would like to share a report on intradermal delivery of vaccines that was commissioned by PATH's Disposable Jet Injector Project and Project Optimize (a collaborative project between WHO and PATH). The report was authored by Julian Hickling and Rebecca Jones from Working in Tandem Ltd. The purpo...

Dear Moderator, I just wanted to know through you, if the same technology can be available for DPT or pentavalent vaccine, so that remote areas could be served well. Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology) Directorate of Health Safety and Regulation,Himachal Pra...

Dear Padmini VPPAG is currently consulting on a paper on the generic Preferred Product Profile (gPPP) for new vaccines used by national programmes in developing countries. The document is currently open for consultation until July 15th. (see attached) Kindly find it at our site: http://sites.googl...

In partnership with Arecor and the University of Colorado Denver School of Pharmacy, PATH published findings in this month’s issue of Human Vaccines (volume 5, issue 8) that describe a new hepatitis B vaccine formulation exhibiting nine week stability at 55°C and at least six month stability at both...

In the course of the revision of the WHO Multi-dose Vial Policy (MDVP) we came across the question if there were any vaccines in multidose vials that had to be discarded less than 6 hours after having been opened. Some package inserts seem to indicate this, but it is not clear whether it would deter...

On behalf of the chair of the Technologies and Logistics Advisory Committee (TLAC, http://www.who.int/immunization_deliver ... index.html) of WHO, Bruce Weniger, we are seeking ideas from the TechNet community for two new graphic “visual cues” for use on vaccine vials to guide health workers for whe...

Public Sector and Industry: Working Together to Better Meet Developing Country Needsby Debra D. Kristensen, Senior Technical Officer and Policy Advisor, PATH, and Christopher B. Nelson, Senior Director, Medical Affairs and Policy, Merck & Co, Inc. Originally established in 2007 by the GAVI Allia...

POST 01308E: APPLICABILITY OF CDC’S INTRAMUSCULAR INJECTION RECOMMENDATIONS IN DEVELOPING COUNTRIES 20 AUGUST 2008 ******************************************* For most childhood vaccines, intramuscular injection is the preferred route of administration. The vastus lateralis muscle of the t...

POST 01298E: NEEDLE-FREE INJECTORS FOLLOW-UP ON POST 01292E 3 AUGUST 2008 ******************************************* PATH is researching the use of disposable-cartridge jet injectors (DCJIs) for the delivery of vaccines in developing-country public-sector immunization programs. DCJIs pot...

POST 01295E: NEED FOR A FEASIBILITY BASELINE FOR MEDICAL WASTE DISPOSAL METHODS 29 JULY 2008 ******************************************* Vijay Machcha from ITPI stresses the need to introduce the concept of baseline for medical waste disposal technologies just as it is done for CDM projects. ...

POST 01292E: NEEDLE-FREE/COLD CHAIN-FREE VACCINE DELIVERY 20 JULY 2008 ******************************************* A peep into the future with regard to needle-free vaccine delivery reveals that innumerable innovative technologies are being researched to deliver vaccines. These range from aeros...

POST 01278E: VVM REFERENCES—ADDENDUM FOLLOW-UP ON POST: 01277E 11 JUNE 2008 ******************************************* Dear moderator, The first reference as indicated at the end of the below posting is an old document that is NOT valid any more. It seems that this document has sl...

POST 01277E: VVM—A WHO-PREQUALIFIED AND VALIDATED TOOL FOLLOW-UP ON POSTS: 01264E, 01266E, 01275E 10 JUNE 2008 ******************************************* The query regarding VVM reliability has generated a fair number of responses--a few heated ones too. An interesting diversion here be...

POST 01275E: HOW RELIABLE IS THE VVM? FOLLOW-UP ON POSTS: 01264E, 01266E 4 JUNE 2008 ******************************************* Rajesh Sood raises questions about the reliability of VVM in the context of out-of-cold-chain practices and recommends conventional safeguards. ----------- ...

POST 01273E: CONTINUING THE DEBATE ON ENERGY FOR HEALTH: FINANCIAL INSTRUMENTS/SYRINGE MANUFACTURE AND ENERGY USE FOLLOW-UP ON POSTS: POSTS 01265E, 01269E 29 MAY 2008 ******************************************* Rowan Wagner takes the discussion a little further by posing questions about l...

POST 01272E: LOW-TECH SOLUTIONS IMPROVE IMMUNIZATION COVERAGE--THE TRACKING BAG STORY 26 MAY 2008 ******************************************* Tasnim Partapuri and his colleagues from IMMUNIZATIONBasics, India share this story about how tracking bags have enabled health workers in some Indian st...

POST 01266E: BROADENING THE USE OF THE VVM 16 MAY 2008 FOLLOW UP ON POST 01264E: ******************************************* Hans Everts responds to Joanie Robertson’s request for out-of-cold-chain vaccine distribution experiences and asks for a proactive approach to VVM. He says the n...

POST 01182E : RETRACTABLE SYRINGE Follow-up on Posts 01166E and 01171E 5 November 2007 ____________________________________ In response to Vijay Kiran’ contribution, Prabir Chatterjee from India provides the following information. On the same site a would-be interesting link "Disp...

POST 01176E : PIS/PQS 24 October 2007 ____________________________________ Dear all, WHO PQS secretariat is happy to announce official release of the PQS E10 "safety box for the disposal of used sharps" product specifications and verification protocol which were approved by the PQ...

POST 01171E : RETRACTABLE SYRINGE Follow-up on Post 01166E 14 October 2007 ____________________________________ [log in to unmask]">Vijay Kiran from India contributes the following comments raising again an important issue of disposal. We have discussed sharps disposal many times...

POST 01166E : RETRACTABLE SYRINGE 3 October 2007 ________________________________ Carib Nelson from PATH is sending you the summary of the following report "Evaluation of a Retractable Syringe in South Africa". As said in his message, the full report is available upon request. NO...

POST 01162E : NEEDLE REMOVER ASSESSMENT 26 September 2007 _______________________________________ It is Guyana’s turn to publish a needle removers’ assessment (865K). It was sent by Nicole Dupré of Initiatives Inc., and forwarded with very positive comments by James Cheyne and Carib Nelso...

POST 01142E : PQS DOCUMENTS : DRAFTS FOR COMMENTS 16 August 2007 _____________________________ Dear all, Final drafts of the PQS E10 category performance_ specifications and verification_protocol for safety box for the disposal of used sharps are now available. We would appreciate your com...

POST 01118E : ORAL POLIO VACCINE COLOUR Follow-up on Post 01050E, 01058E, 01100E and 01107E 8 July 2007 ______________________________________ No other comment or reply were received on this topic. Thus [log in to unmask]">Jacqueline Fournier-[log in to unmask]">Caruana, ...

POST 01117E : VVM ANNIVERSARY Follow-up on Posts 01101E and 01106E 5 July 2007 _____________________________________ Ãœmit Kartoglu from WHO/HQ replies to [log in to unmask]">Robert [log in to unmask]">Steinglass _____________________________________ Dear Robert, ...

POST 01108E : NEEDLE REMOVER EVALUATION 19 June 2007 _____________________________________ NOTE : Adjustments, to be expected, have been made to the Expert database, to solve the few reported problems, especially those concerned with updating one's own data. Some modifications to the design h...

POST 01107E : ORAL POLIO VACCINE COLOUR Follow-up on Post 01050E, 01058E and 01100E (An archive error occurred in this last posting and only attachments were retained in the archives) 17 June 2007 _____________________________________ The first message is from [email=%3Ca%20href=][log in t...

POST 01106E : VVM ANNIVERSARY Follow-up on Post 01101E 15 June 2007 _____________________________________ This is a really excellent posting, full of interesting stories, interviews and policy statements. Congratulations to everyone who labored so hard over so long a period. The intervie...

POST 01102E : EVALUATION OF SYRINGE MELTING 9 June 2007 _____________________________________ PATH conducted a field evaluation of 3 prototype syringe melters in Indonesia. These low-cost approaches to syringe melting used local fuel, such as wood, coconut husks, or stoves, as heat sources....

OST 00101E : VVM ANNIVERSARY 2 June 2007 __________________________________ NOTE : I will be away for about one week in remote areas, and may not have access to Internet. Consequently, TechNet may be silent for some time. I have to use Webmail today and no function to insert links. So al...

POST 01100E : ORAL POLIO VACCINE COLOUR Follow-up on Posts 01050E and 01058E 30 May 2007 ____________________________________ Discussed back in February, the question of OPV color is revisited by [log in to unmask]">Salah [log in to unmask]">Haithami from Sudan who has a ...

POST 01092E : VIAL SIZE : A REQUEST FROM GAVI 13 May 2007 _____________________________________ NOTE: Despite innumerable tests, formatting of postings was inappropriate for top and bottom banners. My apologies! These problems have now been resolved. Thank you for your patience. -----------...

TECHNET21 E-FORUM Technical network for strengthening immunization services Contributions to: mailto:[email protected] or use your reply button! __________________________________________________________ POST 01089E : NEEDLE REMOVER EVALUATION 6 May 2007 ___________________________________...

Content-Type: text/html TECHNET21 E-FORUM Technical network for strengthening immunization services Contributions to: mailto:[log in to unmask] or use your reply button! __________________________________________________________ POST 01061E : VVM USE Follow-up on Posts 01028E, 01035E, 01...

POST 01059E : DILUENTS Follow-up on Post 01054E 27 February 2007 _______________________________ This posting contains three contributions. The first is from Femi Odebgami (mailto:[email protected]) from Nigeria. The second is from Karan Singh Sagar (mailto:[email protected])...

POST 01058E : ORAL POLIO VACCINE COLOUR Follow-up on Post 01050E 25 February 2007 _______________________________ Hans Everts (mailto:[email protected]) from WHO replies to Jedeth Mamora's question on OPV colour. _______________________________ As a response to the message from Jed...

POST 01056E : USE OF ALCOHOL FOR VACCINE INJECTIONS Follow-up on Posts 01029E, 01036E, 01044E and 01051E 20 February 2007 _______________________________ I thought that the last posting would end the debate on this topic. But three more contributions were received. The first is from...

POST 01054E : DILUENTS 16 February 2007 ________________________________________ Vijay Kiran (mailto:[email protected]) from India has the following two questions here below. ________________________________________ Dear TechNet, We stress on the need to use correct diluents for ...

POST 01053E : VVM USE Follow-up on Posts 01028E, 01035E, 01042E and 01050E 14 February 2007 ________________________________________ This posting contains three contributions, from : 1. Vijay Kiran (mailto:[email protected]) from India. 2. Hans Everts (mailto:[email protected]) from ...

POST 01051E : USE OF ALCOHOL FOR VACCINE INJECTIONS Follow-up on Posts 01029E, 01036E and 01044E 8 February 2007 ________________________________________ This posting contains three contributions. I believe that this will likely settle the issue. The first is from Serge Ganivet (mail...

Post 01050E : VVM USE Follow-up on Posts 01028E, 01035E and 01042E 5 February 2007 ________________________________________ This posting contains two contributions. The first is from Jedeth Mamora (mailto:[email protected]) from Indonesia who asks another question, bringing a new as...

POST 01044E : USE OF ETHANOL FOR VACCINE INJECTIONS Follow-up on Posts 01029E and 01036E 23 January 2007 ___________________________________________ Akhter Hamid (mailto:[email protected]) from WHO/Bangladesh is restating the question originally asked by Jedeth Mamora. David Hipgr...

POST 01042E : VVM USE Follow-up on Posts 01028E and 01035E 19 January 2007 _______________________________________ In reaction to Subhash Choudhury's anecdote on VVM use, five contributions were received, from 1. Anil Varshney (mailto:[email protected]) from India 2. Enrique...

POST 01029E : USE OF ETHANOL FOR VACCINE INJECTIONS Follow-up on Post 01029E 8 January 2007 _______________________________________ Only one contribution was received so far following Jedeth Mamora's question, from Anil Varshney (mailto:[email protected]) from India. I couldn't ...

POST 01035E : VVM USE Follow-up on Post 1028E 5 January 2007 ____________________________________ Following Ãœmit's request for narratives, Subhash Choudhury (mailto:[email protected]) from India submitted the one below and he requests your opinion. ______________________...